BUMBLE
LIVE

Serial Number

88733330

Owner

Bumble Holding Limited

Attorney

Winfield B. Martin

Filing Date

Dec 19, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BUMBLE Trademark

Serial Number: 88733330

BUMBLE is a trademark filed by Bumble Holding Limited on December 19, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bumble Holding Limited (305 trademarks)

1 Blossom Yard,

Entity Type: 98

Trademark Details

Filing Date

December 19, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceuticals, namely, antibacterial pharmaceuticals, ocular pharmaceuticals, pharmaceuticals for the treatment of viral infections, pharmaceuticals for the treatment of viral diseases, therapeutic pharmaceuticals for the treatment of sexually transmitted infections, pharmaceuticals for the treatment of hormonal disorders, injectable contraceptives, inducers of erections, effervescent analgesic pharmaceutical preparations, bismuth preparations for pharmaceutical purposes, anti-infectives, royal jelly for pharmaceutical purposes, pharmaceutical preparations for treating sunburn, pharmaceutical preparations for skin care, balms for pharmaceutical purposes, pharmaceutical skin lotions, anti-diabetic pharmaceuticals, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for treating chemical imbalances, pharmaceutical agents affecting sensory organs, pharmaceutical agents affecting metabolism, analgesic and muscle relaxant pharmaceutical preparations, pharmaceutical preparations for treating dandruff; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; medical preparations, namely, diagnostic preparations for medical purposes; medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; veterinary preparations, namely, antioxidants and diagnostic preparations for veterinary purposes; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food adapted for medical use; dietetic substances, namely, dietetic preparations adapted for medical purposes; dietetic foods adapted for veterinary use; dietary supplements for humans and animals; medical plasters; material for dressings, namely, wading for dressings; medicated lotions and creams, namely, anti-fly lotion, calamine lotions, sports cream for relief of pain, orgasm creams, topical analgesic creams, anti-itch creams, antibiotic creams, and medicated creams for dermatological use; medicated lotions and creams, namely, medicated hair lotions, medicated after-shave lotions, medical creams for skin care, medicated cream soap, and medicated lotions and creams for the care of sunburn; medicated skin care preparations, namely, antiseptic creams; medicated skin care preparations, namely, nappy-rash creams; dietary supplements consisting of vitamins; dietetic preparations adapted for medical purposes; dietary and nutritionally fortified food products adapted for medical use, namely, dietary supplements; vitamins and dietary supplements; dietary supplemental drinks in the nature of mineral beverages; dietary supplemental drinks in the nature of vitamin beverages; vitamin preparations in the nature of food supplements; dietary supplement drinks; flaxseed dietary supplements; linseed dietary supplements; protein dietary supplements; pea protein dietary supplements; lecithin dietary supplements; sunflower lecithin dietary supplements; preparations of vitamins; food supplements; health food supplements; herbal supplements for boosting energy; royal jelly dietary supplements; therapeutic and dietary products and preparations containing pollen, namely, processed bee pollen for medicinal or therapeutic purposes; herbal honey throat lozenges; vitamin and mineral supplements; vitamin and mineral supplements containing pollen and honey; rubbing compounds and anti-inflammatory gels containing pollen and honey for medical purposes; material for stopping teeth; dental wax; disinfectants; fungicides; herbicides; personal sexual lubricants; sexual stimulant gels; sanitary sterilizing preparations; hand sanitizers; sanitary preparations for medical use

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 1, 2026 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 1, 2026 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 1, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 1, 2026 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 7, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 7, 2026 GNSL
SUSPENSION LETTER WRITTEN
Mar 7, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 12, 2026 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 30, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 30, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 30, 2026 COAR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 17, 2025 GNFN
FINAL REFUSAL E-MAILED
Nov 17, 2025 GNFR
FINAL REFUSAL WRITTEN
Nov 17, 2025 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 10, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 10, 2025 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 2, 2025 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 1, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 1, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 3, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 3, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 3, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 18, 2024 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 25, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 25, 2024 COAR
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 16, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 16, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jan 16, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 13, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 13, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 13, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 9, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 5, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 5, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 5, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 5, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 7, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 7, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 7, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2021 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 23, 2021 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 15, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 15, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 15, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2020 CRFA
ASSIGNED TO LIE
Sep 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2019 NWOS
NEW APPLICATION ENTERED
Dec 23, 2019 NWAP